Navigation Links
PharmAthene to Present at the BIO CEO & Investor Conference 2008
Date:2/6/2008

ANNAPOLIS, Md., Feb. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that David P. Wright, President and Chief Executive Officer of PharmAthene, will present at the BIO CEO & Investor Conference 2008, in New York, NY on Wednesday, February 13, 2008 at 2:00 p.m. The presentation is scheduled to take place in the Basildon Room at the Waldorf Astoria Hotel.

PharmAthene's presentation will be available via webcast on the company's website at http://www.pharmathene.com. A link to access the webcast will be accessible from both the homepage and the investor relations pages of the PharmAthene corporate website. For assistance, contact Stacey Jurchison at 410-269-2610.

About PharmAthene, Inc.

PharmAthene (Amex: PIP) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead programs include Valortim(TM) for the prevention and treatment of anthrax infection and Protexia(R) for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information on PharmAthene, please visit http://www.pharmathene.com.


'/>"/>
SOURCE PharmAthene Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
6. Avicena Group to Present at Noble Financial Conference
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CEL-SCI to Present at the Noble Financial Conference
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...v. 30 The Michael J. Fo... announced $1.5 million in total awards to six res...-modifying therapies for Parkinson,s disease. The ... Drug Discovery for Parkinson,s Disease program, ...c (NYSE: ELN ), a neuroscience-based biotechnolo...
(Date:11/30/2009)...HUN, China and LOS ANGELES, Nov. 30 /PRNewswire-As...c. (OTC Bulletin Board: CYXN; ,China Yongxin,Pharm...rer, distributor and,retailer of pharmaceuticals i...eted preparation for distribution of medicines on ...vernment recently formalized the nation,s Essentia...
(Date:11/30/2009)...COPENHAGEN, Nov. 30 Exiqon A/S (NA...he Harvard Medical School ICCB-Longwood Screening ...A Screening Center of Excellence. ICCB-L supports...ciated hospitals and institutions, for high-throug...s. ,, MicroRNAs are a novel class of small, non...
(Date:11/28/2009)... The Vanuatu National Advisory Committee on Climat...nication (SNC) Project in collaboration with the V.... of New Zealand have generated preliminary climat... the background for the country’s SNC report...Climate Change (UNFCCC). , ...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4
...ilwaukee, Wis. - US Signal , a Grand Rapids-base... its fiber optic network with seven additional acc...ny, which serves Midwestern enterprise and carrier... 31 of this year. , ,US Signal,s network deployme...g around Milwaukee and powered by the Cisco opti...
...adison, Wis. - The recommendations of a state tec...sconsin Act 255 , the tax-credit program designed ...ompanies, might go unheeded due to the state,s fis...t the act,s purpose, according to state officials....onsin Technology Council called for removing inve...
...The Dow Jones Industrials had a fabulous year an... itself had a very solid year, by a large margin. ...ex, trended differently, mostly because the differ...ex, which holds many more companies, stocks and re...y (larger and smaller companies), was flat for the...
Other Biology Technology:Will there be more money for investment credits? 22006: A mixed blessing for Midwest life science companies 22006: A mixed blessing for Midwest life science companies 32006: A mixed blessing for Midwest life science companies 42006: A mixed blessing for Midwest life science companies 52006: A mixed blessing for Midwest life science companies 62006: A mixed blessing for Midwest life science companies 72006: A mixed blessing for Midwest life science companies 82006: A mixed blessing for Midwest life science companies 92006: A mixed blessing for Midwest life science companies 102006: A mixed blessing for Midwest life science companies 11
(Date:11/26/2009)...RSA (methicillin-resistant Staphylococcus Aureus ...ihilation as low-temperature plasma prototype devi... and unfailing bactericidal cocktails. , Two pro...ent disinfection of healthy skin (e.g. hands and f... can pose a lethal threat; and another to shoot ba...
(Date:11/25/2009)...n September 11, firefighters, police officers and ... in the World Trade Center complex. They battled t...rched for survivors, tackled fires and evacuated a...ined an estimated 17,000 people. And making their ...tions: frightened workers and their relatives jamm...
(Date:11/25/2009)...wo Kent State University assistant professors rece...undation (NSF) to continue research beneficial to ...tal $890,000. , Christopher Blackwood, assistant...s, was awarded grants to support two separate rese...mbling Litter Decomposer Communities and Functions...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2aTyr Pharma to Present at BioPharm America 2009 14028 1aTyr Pharma to Present at BioPharm America 2009 14028 2Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 1Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 2Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 3Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 4Video 3A Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than 244 6 Million 57088 5Haemacure Reports on Current Activities and Third Quarter 2009 Financial Results 57085 1Haemacure Reports on Current Activities and Third Quarter 2009 Financial Results 57085 2Haemacure Reports on Current Activities and Third Quarter 2009 Financial Results 57085 3Haemacure Reports on Current Activities and Third Quarter 2009 Financial Results 57085 4
...esearchers from the University of Pennsylvania Sch...activates several genes known to regulate the deve...d-producing stem cells, in bone marrow. Knowing th...treatments for such blood diseases as leukemia, as...n the context of bone-marrow and peripheral-stem-c...
...oots are crucial for the development of strong, he...es are involved in the development of roots was st...niversity Institute for Biotechnology (VIB) connec...te plant genome in order to identify the genes tha...ts. For the first time, they are unraveling the ge...
...armers, veterinarians and meat processors who rout...ve a markedly increased risk of infection with flu...nded in part by the National Institute of Allergy ...al Institutes of Health (NIH). , While the findin...her risk of infection coupled with the fact that p...
Other Biology News:Master regulatory gene found that guides fate of blood-producing stem cells 2Plant genes identified that can form basis for crops better adapted to environmental conditions 2Agricultural workers at increased risk for infection with animal flu viruses 2Agricultural workers at increased risk for infection with animal flu viruses 3
... Slotted migration Chamber lid allows easy gel ..., One-touch connectors for easy set up between p...ety-switch prevents current flow if the lid is rem... and durability., Remote control can be easily o...
... ProFound Label Transfer Sulfo SBED Protein:Protei... as Label Transfer has rapidly gained traction as ...ry. A growing number of publications feature the e...ransfer Reagent to study a variety of issues relat...
... MULTI-FUN Incubator is a compact benchtop and sta...ocessor controller with a large display screen to .... Air circulation inside to evenly distribute temp...y calibrated from the microprocessor controller. B...
... Biotin label transfer is fast emerging as a power... confirmation. Until now, only amino groups have b...ts such as our Sulfo-SBED. Sulfhydryl-reactive Mts...Biotin, are exciting additions to the protein inte...
Biology Products: